Mesenchymal Stem Cells: A New Approach for Treating Bronchopulmonary Dysplasia | Biomedgrid

In spite of improved clinical management premature babies are highly susceptible to several neonatal related-morbidities, namely respiratory, neurological, and gastrointestinal. Bronchopulmonary dysplasia (BPD) is the most common lung disorder in premature babies. Present therapeutic options are mainly supportive and do not completely cure BPD, mainly because of its multifactorial pathogenesis. Mesenchymal stem/stromal cells (MSCs) have materialized as a highly promising therapeutic option for alleviating BPD. The many facets of this novel therapy are discussed in this review